연구동향 분석
박사

梔子와 Ursolic acid의 胃 損傷에 대한 防禦 效果 硏究 = A Study of the protective effects on gastric lesion of Gardeniae fructus and Ursolic acid

김선회 2015년

논문상세정보
인용/피인용
' 梔子와 Ursolic acid의 胃 損傷에 대한 防禦 效果 硏究 = A Study of the protective effects on gastric lesion of Gardeniae fructus and Ursolic acid' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • apoptosis
  • h. pylori
  • proton pump
  • ursolic acid
  • 치자
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
502 0

0.0%

' 梔子와 Ursolic acid의 胃 損傷에 대한 防禦 效果 硏究 = A Study of the protective effects on gastric lesion of Gardeniae fructus and Ursolic acid' 의 참고문헌

  • 李載熙 著, 『圖說韓方 藥理 藥能의 臨床應用』
    學林社, p183-185 [1985]
  • 李承吉 著, 『以導 傷寒論講座』
    동신출판사, p198-220, p251-284, p287-303 [2000]
  • 陸昌洙 編著, (1993) 『現代方藥合編 增補版』, 癸丑文化史, p320-321
  • 龍野一雄 著, 李承吉 推薦, 李載熙 譯編, (1999) 漢方入門講座 上卷, 癸丑 文化社, p125, p127, p144, p146
  • 한약제제학 교재편찬위원회, 『한약제제학』
    도서출판 신일북스, p149-150 [2013]
  • 한약재의 생리활성 성분 분석연구 (현삼,치자)
    송경식 이동웅 식품의약품 안전청 한약재 평가기술 과학화 연구 [2008]
  • 한국임상약학회, 『PHARMACOTHERAPY 약물치료학』, 수정판
    도서출판 신일북스, p289-296, p224-227 [2006]
  • 한국인에 흔한 위암, 헬리코박터균 관련성 밝혔다
    최동진 HelloDD.com Korea's No1 Media in Science & Industry, 2014.08.05 [2014]
  • 하고초(夏枯草,Prunellae Herba)로부터 Ursolic acid의 함량 분석
    강삼식 김주선 원도희 이경순 장승엽 생약학회지 v.31,no.4, pp.416-420 [2000]
  • 편집부편, 전통염색공예
    한국문화재보호재단 [2005]
  • 치자의 염색지속력과 모발 손상 보호효과
    문재원 이복자 한국미 용학회지, 제20권 제1호, pp.73-82 [2014]
  • 치자섭취와 복합운동이 비만중년여성의 신체구성, 혈중지질과 아디포 싸이토카인에 미치는 영향
    신재숙 허유섭 한국체육과학회 지, 제22권 제3호, pp. 1029-1039 [2013]
  • 치자꽃 향기
    진효임 아이테르 [2012]
  • 치자꽃 연가
    김소해 한국문학방송 [2013]
  • 치자, 치자꽃의 효능과 부작용, 주의사항, 냉증과 열증
    김달래 체질과 음식 188 [2013]
  • 이상규시선집
    이상규 토담미디어 [2012]
  • 오매추출물에 함유된 Ursolic acid에 의한 Helicobacter pylori의 Urease 활성억제
    박찬엘, 박창호 Korean Chem.Eng.Res, 51(5), 591-596. [2013]
  • 식품의약품 안전평가원/생약종합정보시스템, www.mfds.go.kr/herbmed/ir 오화자, 치자의 염색성, 항균성, 소취성에 관한 연구
    대한가정학 회지: 제40권 11호 [2002]
  • 소화생리. In: 생리학. 개정5판
    강두희 이중우 신광출판사, 11:1-78 [1998]
  • 대황추출물 및 유효성분의 위 손상에 대한 방어 효과
    황인영 박사학위, 덕성여자대학교 약학과, 한국. [2013]
  • 대한약사회, 『한약제제 해설과 복약지도』
    약사공론, p25, p27, p142, p197, p256, p332 [2006]
  • 근대 중국 한의약의 변천과 발전
    김양일 서울약사회지 2월호, p25-28 [2014]
  • 건강보험심사평가원
    최근3년 한국인의 위장질환 실태 [2014]
  • 黃連解毒湯이 Collagenase에 의한 흰쥐의 뇌출혈 및 뇌부종에 미치는 영향
    구자승 박사학위, 경희대학교 동서의학대학원 동서의학과, 한국 [2011]
  • 黃?連解毒湯 물 추출물의 항염증효과
    김대희 박사학위, 대구한의대학교대학원, 한국 [2009]
  • 魚炅晶, , 茵蔯蒿湯의 항알레르기에 대한 실험적연구, 박사학위, 東義大學校 大學院 韓醫學科
    한국 [2010]
  • 韓藥委員會 調劑指針硏究小委員會 編著, 金昌玟 李淑姸 監修, (1995) 『韓藥調劑指針書解說』,社團法人大韓藥師會, p150, p162, p205.
  • 韓相允, 金東熙, 金聖勳, 傷寒論 梔子?湯類에 關한 硏究
    大田大 學校 韓醫學硏究所論文集 第7卷 第2號 [1999]
  • 韓國藥師古方硏究會, 『疾患別 韓藥 臨床의 實際』
    (주)YSP, p66, p166,p227-228, p358,p399, p677, p773-777 [2008]
  • 韓國生藥學校授協議會編著, (1995)『本草學』,社團法人 大韓藥師會, p133, p163-165, p182.
  • 許慈京, , 夏枯草의 ursolic acid가 파골세포 분화 억제에 미치는 영향, 박사학위, 慶熙大學校 大學院 韓醫學科
    한국 [2013]
  • 湯本求眞纂著,朱甲悳譯, (1983)『皇漢醫學第3卷』, 癸丑文化史, p141,p150
  • 湯本求眞纂著,朱甲悳譯, (1983)『皇漢醫學 第2卷』,癸丑文化史, p284-301
  • 湯本求眞纂著,朱甲悳 譯, (1983)『皇漢醫學 第1卷』,癸丑文化史, p37-38
  • 梔子의 부위별 Geniposide정량 및 항산화효능비교, Kor.J
  • 朴盛洙, 廉泰煥 共著, (1977)『現代韓方講座 全4卷』, 醫藥社, p87-93.
  • 寺澤捷年 著, 曺基湖 辛吉祥 共譯, 『서양의학자의 한방진료학』
    집문당, p13-14 [1997]
  • 孫賢秀, , Ursolic acid가 HepG2 세포의 세포사멸에 미치는 효과 및 기전에 관한 연구, 박사학위, 慶熙大學校大學院 韓醫學科
    한국 [2013]
  • 大塚敬節 著, 朴鐘甲 譯, (1984) 『臨床應用 傷寒論解說』, 書苑堂, p240-249, p367-389
  • 十年 後의 藥師 像
    김양일 [2014]
  • 主編; 劉冠軍, 南征. 編著; 朴志賢, 南貞淑, 朴春竹, 殷玉華, 李忠寬, 金東 植, 『簡明 中醫學叢書2권』
    一中社, p129-146 [1994]
  • 上海科學技術出版社 小學館編, (1985) 『中藥大辭典 第2卷』, 小學館, p1050.
  • β-Glucosidase 처리에 의한 치자추출물의 항염증 활성증진
    김미혜 손동화 최대운 KOREAN J. FOOD SCI. TECHNOL. Vol. 44, No. 3, pp. 331~336. [2012]
  • Yang HJ, Park MJ, Lee HS. (2011) Antioxidative activities and comonents of Gardenia jasminoides. Korean J. Food Sci. Technol.43: 51-57.
  • Wegner M, Borsch G, Schaffstein J, Reuter C and Leuverkus F (1989) Frequency of idiopathic gastric stasis and intestinal transit disorders in essential dyspepsia. J. Clin. Gastroenterol., 11, 625-30.
  • Walt RP, (1992) Misoprostol for the treatment of peptic ulcer and anti-inflammatory drug induced gastroduodenal ulceration, N Eng J Med, 327:1575-80.
  • Walsh JH, Peterson WL, (1995) Drug therapy: the treatment of Helicobacter pylori infection in the management of peptic ulcer disease, NEJM, 333(15):984-991.
  • Viver R. Yadav, Sahdeo Prasad, Bokyung sung, Ramaswamy Kannappan, and Bharat B. Aggarwal, (2010) Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer,Toxins(basel),2(10):2428-2466.
  • Triterpenoid계 식물성분인Oleanolicacid의항노화효과
    김수남 김수현 김승훈 남개원 성대석 이병곤 이소희 태평양기술연구원 피부과학연구소 의약연구소 [2003]
  • Takemori AE, Kupferberg HT and Miller JW (1969) Quantitative studies of antagonism of morphine by nalorphine and naloxone. J. Pharmacol. Exp. Ther., 169, 39-45.
  • Tack J and Lee KJ (2005) Pathophysiology and Treatment of Functional Dyspepsia. J. Clin. Gastroenterol., 39, 211-6.
  • Suetsugu H, Ishihara S, Moriyama N, Kazumori H, Adachi K, Fukuda R, Watanabe M and Kinoshita Y (2000)Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa, J. Lab. Clin. Med. 136, 50-7.
  • Soon-Nang Park and Joong-Ki Kook, (2013) Antimicrobial Activity of Oleanolic Acid, Ursolic Acid, and Sophoraflavanone G against Periodontopathogens, International Journal of Oral Biology, Vol. 38, No. 4 December 3 p149-154.
  • Soohyeon Kim, Minju Song, Byoung-Duck Roh, Sung-Ho Park, Jeong-Won Park, (2013) Inhibition of Streptococcus mutans biofilm formation on composite resins containing ursolic acid, Restorative Dentistry & Endodontics, The Korean Academy of Conservative Dentistry, 38. 2.65-72.
  • Sontag S, et al, (1984) Cimetidine, cigarette smoking and recurrence of duodenal ulcer,N Eng J Med, 311:689-93.
  • Soll AH, (1996) Medical treatment of peptic ulcer disease: practice guideline, JAMA, 275(8):662-629.
  • Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K (1992) Helicobacter pylori infection and chronic gastritis in gastric cancer, J. Clin. Pathol., 45, 319-23.
  • Shay H and Komarov SA, Fels SS and Meranze D (1945) A simple method for the uniform production of gastric ulceration in the rat. Gastroenterol. 4, 43-61.
  • Shamburek RD, Schubert ML, Control of gastric acid secretion, Gastroenterol Clin North Am 1993;21:527-550.
  • Schoenfeld P, Kimmey MB, Scheiman J, et al, (1999) Nonsteroidal anti-inflammatory drug associated gastrointestinal complications-guidelines for prevention and treatment, Aliment Pharmacol Ther, 13:1273-85.
  • Scarpignato C, Capovilla T, Bertaccini G (1980) Action of caerulein on gastric emptying of the conscious rat. Arch. Internationales de Pharmacodynamic et de Ther, 246,286-94.
  • Salcedo JA, AI-Kawas F, (1998) Treatment of Helicobacter pylori Infection, Arch Intern Med, 158:842-850.
  • Reisner, Essentials of Rubin’s pathology 5th Edition 번역 (사) 대한약학회 병태생리학 분과학회
    Emanuel Rubin Howard M. 군자출판사. p357-374 [2013]
  • Raskin JB, White RH, Jackson JE, et al, (1995) Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug induced gastrican duodenal ulcers; a comparison of three regimens, Ann Intern Med, 123:344-50.
  • Piper FW, Macintosh JH, arriotti DE, et al, (1981) Analgesic ingestion and chronic peptic ulcer, Gastroenterology, 80:427-32.
  • Peterson WL, (1991) Helicobacter pylori and peptic ulcer disease, N Eng J MEd 324:1043-8.
  • Peng Tian, (2011) Where West meets East, Nature, VOL 480 S84.
  • Pemberton RE, Strand LJ, (1979)A review of upper gastrointestinal effects on the newer nonsteroidal anti-inflammatory agents, Dig Dis Sci, 24:53-84
  • Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orenteich N, et al, (1991) Helicobacter pylori infection and the risk of gastric carcinoma, N Eng J Med, 335:1127-31.
  • Oyaizu M (1986) Studied on products of browning reaction. Antioxidative activities of products of browning reaction prepared from glucosamine. Jpn. J. Nutr., 44, 307-15.
  • NIH (1994) Consensus development panel on Helicobacter pylori in peptic ulcer disease, Helicobacter pylori in peptic ulcer disease, JAMA, 272:65-69.
  • Mizui T and Dodeuchi M (1983) Effect of polyamines on acidified ethanol induced gastric lesion in rats, Jpn. J. Pharmacol., 33, 939-45.
  • Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N and Hosoki K (1997) Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J. Pharmacol. Exp. Ther., 283, 1000?8.
  • Messer J, Reitman D, Sacks HS, et al, (1983) Association of adrenocorticosteroid therapy and peptic ulcer disease, N Eng J Med, 309:21-4.
  • McCarthy DM, (1991) Sucralfate, N Eng J Med, 325:1017-25.
  • Massimo R and Robert MG (2005) Staging and grading of chronic gastritis, Human Pathol., 36, 228? 33.
  • Marshall BJ, (1995) The 2995 Albert Lasker Medical Research Award Helicobacter pylori, The etiologic sagent for peptic ulcer, JAMA, 274:1064-6.
  • Malagelada JR and Stanghellini V (1985) Manometric evaluation of upper gut symptoms. Gastroenterol., 88, 1223-31.
  • Koleva II, Beek TA, Linssen JPH, Groot A and Evastatieva LN (2002) Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochem. Anal., 13, 8-17.
  • Kojima K, Shimada T, Nagareda Y, Watanabe M,Ishizaki J, Sai Y, Miyamoto K &Aburada M, (2011) Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells, Biol Pharm Bull, 34(10), 1613-1618.
  • Kim JM, Shin JE, Han MJ, Baek NI and Kim DH (2003) Inhibitory Effect of Ginseng Polyacetylenes on Infection and Vacuolation of Helicobacter pylori. Nat. prod. sci., 9, 158-60.
  • Kasuya Y, Urushidani T and Okabe S (1979) Effects of various drugs and vagotomy on indomethacin-induced gastric ulcers in the rat. Jpn. J. Pharmacol. 29, 670-3.
  • Kartz J, (1991) The course of peptic ulcer disease, Med Clin North Am 75:831-41.
  • Jan van der Greef, (2011) All system go, Nature, VOL 480 S 87. Jensen SL, Jensen PF, (1992) Role of sucralfate in peptic ulcer disease, Dis Dis, 10:153-61.
  • James Mitchell Crow, (2011) That healthy gut feeling, Nature, VOL 480 S 88.
  • James B, James MW and John A (2003) Gastritis and Peptic Ulcer. Original Res. Med., 31, 15-8.
  • Hoogerwerf WA, Pasricha PJ, (2006) Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease, 『Goodman & Gilman's the pharmacological basis of therapeutics, 11th ed』, McGraw Hill.
  • HMB와 ursolic acid의 근육 분해 조절에 따른 근육 감소증 억제효과
    노경균 석사학위, 부산대학교, 한국 [2013]
  • H. Wagner, (2004) Natural products chemistry and phytomedicine research in the new millennium: new developments and challenges. ARKIVOC2004(Ⅴii)277-284
  • Guyton AC, Secretory functions of the alimentary tract. In: Guyton AC. Textbook of medical physiology, 8 th ed. Philadelphyia: WB Saunders,1991:709-725.
  • Graham DY, Agrawal NM, Roth SH, (1988) Prevention of NSAID-induced gastric ulcer with misoprostol; multicenter, double-blind, placebo controlled trial, Lancet, 2:1277-80.
  • Galligan JJ and Vanner S (2005) Vanner Basic and clinical pharmacology of new motility promoting agents Neurogastroenterol. Motil., 17, 643?53.
  • Forest G, et al, (1986) Active smoking depresses prostaglandin synthesis in human gastric carcinoma, Ann Intern Med, 104:616-19.
  • Dipiro, PharmD, FCCP외, 번역. 감수 중앙대학교 의과대학 학술연구모임,『PHARMACOTHERAPY A Pathophysiologic Approach 임상약물백과사전 한국어판 6th
    Joseph T. 1』 Joyoon Communications, p905-967 [2007]
  • D-Galactosamine으로 유발된 흰쥐의 간손상에 대한치자두시탕 추출액이 미치는 영향
    김진호 정종길 Kor. J. Herbology 28(2)：17-23. [2013]
  • Cullen DJ, Collins BJ, Christiansen KJ, et al, (1993) Long term risk of peptic ulcer disease in people with Helicobacter pylori infection-a community based study(abstract), Gastroenterology, 104(Suppl 2):A60.
  • Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs, Ann Intern Med, 114:735-40 pocusme
    Daugherty JR Piper JM Ray WA [트리테르펜] 우르솔산 ursolic acid (질병과 자연치유) [1991]
  • Christopher M. Adams at al, (2012) Ursolic Acid Increases Skeletal Muscle and Brown Fat and DecreasesDiet-Induced Obesity, Glucose Intolerance and Fatty Liver Disease. PLoS ONE Volume 7 Issue 6 e39332.
  • Choi, HEojin Jo, Mi-Hwawa-Sook Kim, Soon-Nang Park1, Yun Kyong Lim, Christina K. Kang, and Joong-Ki Kook, (2014) Antimicrobial Effects of Oleanolic Acid, Ursolic Acid, and Sophoraflavanone G against Enterococcus faecalis and Propionibacterium acnes , International Journal of Oral Biology, Vol. 39, No. 2 June 30 p75-79.
  • Cameron A, (1998) Selective Cox-2 inhibitora gather speed, Inpharma, 1122:9-10
  • Blaser MJ, (1999) Helicobacter pylori and the pathogenesis of gastroduodenal inflammation, J Infect Dis,161:626-633.
  • Berardi RR, (2005) Peptic ulcer Disease, Pharmacotheraphy, 『A pathophysiologic approach 6th Ed』, McGrow Hill.
  • Beradi RR, (1996) Peptic ulcer disease and Zollinger-Ellison syndrome, In;Dipiro JT et al, eds. Pharmacotherapy: a pathophygiologic approch 3rd ed, New York Elservier, 697-721.
  • Bae EA, Han MJ, Baek NI and Kim DH (2001) In vitro anti Helicobacter pyloriactivity of panaxtriol isolated from ginseng.Arch. Pharm. Res., 24, 297-9.